Search Results - "Amin, Anmol"
-
1
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors
Published in Molecular cancer research (01-04-2015)“…Phyllodes tumors are rare fibroepithelial tumors with variable clinical behavior accounting for a small subset of all breast neoplasms, yet little is known…”
Get full text
Journal Article -
2
Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management
Published in Advances in anatomic pathology (01-01-2011)“…Bladder urothelial carcinoma is typically a disease of older individuals and rarely occurs below the age of 40 years. There is debate and uncertainty in the…”
Get full text
Journal Article -
3
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma
Published in Virchows Archiv : an international journal of pathology (01-03-2015)“…Although multifocal tumors and non-invasive/invasive components are commonly encountered in surgical pathology, their genetic relationship is often poorly…”
Get full text
Journal Article -
4
Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors
Published in Neoplasia (New York, N.Y.) (01-04-2015)“…Abstract Next-generation sequencing (NGS) has enabled genome-wide personalized oncology efforts at centers and companies with the specialty expertise and…”
Get full text
Journal Article -
5
The Oncomine Cancer Research Panel, a scalable next-generation sequencing system for relevant somatic variant assessment in solid tumors
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
6
Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors12
Published in Neoplasia (New York, N.Y.) (26-04-2015)“…Next-generation sequencing (NGS) has enabled genome-wide personalized oncology efforts at centers and companies with the specialty expertise and infrastructure…”
Get full text
Journal Article